Search

everythinglearnresearchcommunity

for

Search:↓

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Androgens might play a role in the severity of COVID-19.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.

The document's conclusion cannot be provided because the document itself is not accessible or cannot be parsed.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Over 25% of COVID-19 patients had symptoms lasting more than a year.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

There might be a skin condition related to COVID-19.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.